TY - JOUR KW - Medicaid KW - Adherence KW - buprenorphine KW - group-based trajectory models KW - opioid use disorder KW - pharmacoepidemiology KW - Pregnant KW - Trajectory AU - Wei-Hsuan Lo-Ciganic AU - Julie M. Donohue AU - Joo Yeon Kim AU - Elizabeth E. Krans AU - Bobby L. Jones AU - David Kelley AU - Alton E. James AU - Marian P. Jarlenski A1 - AD - Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville, FL, USA.; Department of Health Policy and Management, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.; Department of Health Policy and Management, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.; Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh, Pittsburgh, PA, USA.; Magee-Womens Research Institute, Pittsburgh, PA, USA.; Department of Psychiatry, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.; Pennsylvania Department of Human Services, Harrisburg, PA, USA.; Department of Health Policy and Management, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.; Health Policy Institute, University of Pittsburgh, Pittsburgh, PA, USA.; Department of Health Policy and Management, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA. BT - Pharmacoepidemiology and drug safety C5 - Financing & Sustainability; Healthcare Disparities; Opioids & Substance Use CY - England DO - 10.1002/pds.4647 JF - Pharmacoepidemiology and drug safety LA - eng M1 - Journal Article PB - John Wiley & Sons, Ltd PP - England PY - 2018 SN - 1099-1557; 1053-8569 T1 - Adherence trajectories of buprenorphine therapy among pregnant women in a large state Medicaid program in the United States T2 - Pharmacoepidemiology and drug safety TI - Adherence trajectories of buprenorphine therapy among pregnant women in a large state Medicaid program in the United States U1 - Financing & Sustainability; Healthcare Disparities; Opioids & Substance Use U2 - 30192041 U3 - 10.1002/pds.4647 VO - 1099-1557; 1053-8569 Y1 - 2018 Y2 - Sep 7 ER -